Major new ME/CFS & Long Covid study launches with Imperial College and the ME Association ELAROS is proud to announce the news of our latest investment into ground-breaking research to…
ELAROS announces December 2025 Webinar series 09 December, 10 December, 11 December 2025 The team are excited to share a series of webinars in December 2025 to announce a range of…
ELAROS attends the Medical Research Councils DiMen DTP Day Event In July, two of the ELAORS colleagues Román Rocha Lawrence, R&D Manager, and Jennifer McDonald, PPIE Manager delivered an industry…
ELAROS attends Software Engineering Showcase at Sheffield Hallam University Last week, ELAROS colleagues Henry Robinson, Toby Boud and Oliwia Zwara had the pleasure of attending the Sheffield Hallam University Computer…
Psychometric analysis of the modified C19-YRSm in a prospective multicentre study Published on the 3rd of January 2024 doi: 10.1101/2023.12.22.23300424'Psychometric analysis of the modified Covid-19 Yorkshire Rehabilitation Scale (C19-YRSm) in…
Impact of Long COVID quantified by the European Journal of Health Economics Published on the 26th of December 2023 in the European Journal of Health Economics, doi:10.1007/s10198-023-01653-z'Impact of Long COVID…
Opinion piece published in the British Medical Journal Published on the 10th of August 2023 in the British Medical Journal doi: 10.1136/bmj.p1816 'Digital interactive patient reported outcome measures for long…
ELAROS to part-fund a PhD post at the University of Huddersfield ELAROS is happy to announce its strategic partnership with the University of Huddersfield (UoH) to start work on the…
ELAROS to support a Joint PhD with the University of Leeds, the University of Manchester and the University of Liverpool ELAROS is delighted to be able to announce that we…
C19-YRS becomes the first Clinically Validated Outcome Measure for use in Long COVID Patients ELAROS is pleased to announce on behalf of our C19-YRS clinical partners the first global study…